公开(公告)号：EP3621694A1

公开(公告)日：2020-03-18

申请号：EP18727561.5

申请日：2018-05-09

申请人： Scholar Rock, Inc.

发明人： BUCKLER, Alan ,  CARVEN, Gregory, J. ,  WAWERSIK, Stefan ,  SCHURPF, Thomas ,  MARTIN, Constance ,  DATTA, Abhishek ,  FARMER, Mark, Allen

IPC分类号： A61P35/00 ,  A61K45/06

公开(公告)号：EP4286013A3

公开(公告)日：2024-02-28

申请号：EP23183427.6

申请日：2018-05-09

申请人： Scholar Rock, Inc.

发明人： BUCKLER, Alan ,  CARVEN, Gregory, J. ,  WAWERSIK, Stefan ,  SCHURPF, Thomas ,  MARTIN, Constance ,  DATTA, Abhishek ,  FARMER, Mark, Allen

IPC分类号： A61K45/06 ,  A61P35/00 ,  A61K39/395 ,  A61P11/00 ,  A61P21/00 ,  A61P37/04

摘要： Disclosed herein are LRRC33 inhibiting agents and related methods and uses thereof. More specifically, therapeutic agents for inhibiting LRRC33 effects in vivo are provided. Such agents are useful for the treatment of various disorders involving cells expressing LRRC33 or LRRC33-containing complexes on the surface of cells.

公开(公告)号：EP4286013A2

公开(公告)日：2023-12-06

申请号：EP23183427.6

申请日：2018-05-09

申请人： Scholar Rock, Inc.

发明人： BUCKLER, Alan ,  CARVEN, Gregory, J. ,  WAWERSIK, Stefan ,  SCHURPF, Thomas ,  MARTIN, Constance ,  DATTA, Abhishek ,  FARMER, Mark, Allen

IPC分类号： A61P37/04

摘要： Disclosed herein are LRRC33 inhibiting agents and related methods and uses thereof. More specifically, therapeutic agents for inhibiting LRRC33 effects in vivo are provided. Such agents are useful for the treatment of various disorders involving cells expressing LRRC33 or LRRC33-containing complexes on the surface of cells.